CDNA EBITDA Growth
159.12%TTM
Period ending:
CDNA TTM EBITDA YoY %%
907.38%-4649.79%
2014-12-312026-06-30
Source: Financial Modeling Prep (FMP). Trailing twelve months (TTM). TTM flows use four complete reported quarters. Growth compares with the corresponding period one year earlier.
CDNA ebitda growth history
Year-over-year EBITDA growth rate. The available trailing twelve months (ttm) series contains 47 observations from Dec 31, 2014 to Jun 30, 2026.
| Period ending | EBITDA Growth |
|---|---|
| 159.1199% | |
| 127.3441% | |
| 83.7731% | |
| 42.6907% | |
| 46.846% | |
| 71.7527% | |
| 63.6883% | |
| 54.2986% | |
| 25.7313% | |
| -13.8147% | |
| -31.1737% | |
| -20.9634% | |
| -17.1255% | |
| -65.6633% | |
| -199.4729% | |
| -769.4096% | |
| -3,553.5801% | |
| -1,218.737% | |
| -146.1265% | |
| 40.0882% | |
| 110.058% | |
| 84.2462% | |
| 57.0151% | |
| 33.5632% | |
| -18.5515% | |
| -58.4445% | |
| -67.2886% | |
| -52.4573% | |
| 35.9279% | |
| 42.4255% | |
| 43.6639% | |
| 47.5148% | |
| -72.8861% | |
| -13.8655% | |
| 11.0239% | |
| 4.1641% | |
| 46.0477% | |
| 6.1194% | |
| -109.607% | |
| -261.427% | |
| -668.561% | |
| -2,849.6855% | |
| -2,167.8776% | |
| -1,282.4859% | |
| -4,112% | |
| -400% | |
| 369.5876% |
Compare ebitda growth
All CDNA financial metrics · CDNA stock overview · How to interpret financial metrics
